» Articles » PMID: 21068189

Cardiovascular Imaging for Assessing Cardiovascular Risk in Asymptomatic Men Versus Women: the Multi-ethnic Study of Atherosclerosis (MESA)

Abstract

Background: Coronary artery calcium (CAC), carotid intima-media thickness, and left ventricular (LV) mass and geometry offer the potential to characterize incident cardiovascular disease (CVD) risk in clinically asymptomatic individuals. The objective of the study was to compare these cardiovascular imaging measures for their overall and sex-specific ability to predict CVD.

Methods And Results: The study sample consisted of 4965 Multi-Ethnic Study of Atherosclerosis participants (48% men; mean age, 62±10 years). They were free of CVD at baseline and were followed for a median of 5.8 years. There were 297 CVD events, including 187 coronary heart disease (CHD) events, 65 strokes, and 91 heart failure (HF) events. CAC was most strongly associated with CHD (hazard ratio [HR], 2.3 per 1 SD; 95% CI, 1.9 to 2.8) and all CVD events (HR, 1.7; 95% CI, 1.5 to 1.9). Most strongly associated with stroke were LV mass (HR, 1.3; 95% CI, 1.1 to 1.7) and LV mass/volume ratio (HR, 1.3; 95% CI, 1.1 to 1.6). LV mass showed the strongest association with HF (HR, 1.8; 95% CI, 1.6 to 2.1). There were no significant interactions for imaging measures with sex and ethnicity for any CVD outcome. Compared with traditional risk factors alone, overall risk prediction (C statistic) for future CHD, HF, and all CVD was significantly improved by adding CAC, LV mass, and CAC, respectively (all P<0.05).

Conclusions: There was no evidence that imaging measures differed in association with incident CVD by sex. CAC was most strongly associated with CHD and CVD; LV mass and LV concentric remodeling best predicted stroke; and LV mass best predicted HF.

Citing Articles

Cardiac Magnetic Resonance Imaging in Diagnostics and Cardiovascular Risk Assessment.

Matusik P, Mikrut K, Bryll A, Popiela T, Matusik P Diagnostics (Basel). 2025; 15(2).

PMID: 39857062 PMC: 11764230. DOI: 10.3390/diagnostics15020178.


Sex differences in prevalence and characteristics of imaging-detected atherosclerosis: a population-based study.

Swahn E, Lawesson S, Alfredsson J, Fredrikson M, Angeras O, Duvernoy O Eur Heart J Cardiovasc Imaging. 2024; 25(12):1663-1672.

PMID: 39158095 PMC: 11601724. DOI: 10.1093/ehjci/jeae217.


Eicosapentaenoic acid and Arachidonic acid Protection Against Left Ventricle Pathology: the Multi-Ethnic Study of Atherosclerosis.

Shearer G, Block R, Huang S, Liu L, Herrington D, Tsai M medRxiv. 2024; .

PMID: 38883788 PMC: 11177919. DOI: 10.1101/2024.06.05.24308494.


Protocol: Can coronary artery calcium score identified on thoracic planning CT scans be used and actioned to identify cancer survivors at high risk of cardiac events: A feasibility study in cancer survivors undergoing radiotherapy in Australia.

Dalla Via J, Stewart N, Kennedy M, Cehic D, Purnell P, Toohey J BMJ Open. 2023; 13(7):e072376.

PMID: 37463809 PMC: 10357636. DOI: 10.1136/bmjopen-2023-072376.


Defining left ventricular remodeling using lean body mass allometry: a UK Biobank study.

Gomes B, Hedman K, Kuznetsova T, Cauwenberghs N, Hsu D, Kobayashi Y Eur J Appl Physiol. 2023; 123(5):989-1001.

PMID: 36617359 DOI: 10.1007/s00421-022-05125-9.


References
1.
Finn A, Kolodgie F, Virmani R . Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology. Arterioscler Thromb Vasc Biol. 2009; 30(2):177-81. DOI: 10.1161/ATVBAHA.108.173609. View

2.
Gardin J, Lauer M . Left ventricular hypertrophy: the next treatable, silent killer?. JAMA. 2004; 292(19):2396-8. DOI: 10.1001/jama.292.19.2396. View

3.
Greenland P, Bonow R, Brundage B, Budoff M, Eisenberg M, Grundy S . ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology.... Circulation. 2007; 115(3):402-26. DOI: 10.1161/CIRCULATIONAHA..107.181425. View

4.
Pencina M, DAgostino Sr R, DAgostino Jr R, Vasan R . Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2007; 27(2):157-72. DOI: 10.1002/sim.2929. View

5.
Kamath S, Markham D, Drazner M . Increased prevalence of concentric left ventricular hypertrophy in African-Americans: will an epidemic of heart failure follow?. Heart Fail Rev. 2006; 11(4):271-7. DOI: 10.1007/s10741-006-0228-8. View